Financhill
Back

Pluri 10K Form

Sell
41

PLUR
Pluri

Last Price:
4.87
Seasonality Move:
22.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PLUR News And Ratings

See the #1 stock for the next 7 days that we like better than PLUR

PLUR Financial Statistics

Sales & Book Value

Annual Sales: $326K
Cash Flow: $-4.27M
Price / Cash Flow: 0
Annual Sales: $-0.96
Price / Book: 0

Profitability

EPS (TTM): -4.12000
Net Income (TTM): $-21.81M
Gross Margin: $322K
Return on Equity: -438.78%
Return on Assets: -55.22%

Pluri Earnings Forecast

Key Pluri Financial Ratios

  • The Gross Profit Margin over the past 17 years for PLUR is 98.77%.
  • The Selling, General & Administrative Expenses for PLUR have been equal to 3,077.91% of Gross Profit Margin.
  • The Research & Development expenses have been 3,817.79% of Revenue.
  • The Interest Expense is -4.15% of Operating Income.
  • The Net Earning history of PLUR is -6,407.36% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

Pluri Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PLUR
Website: pluri-biotech.com

Debt

Debt-to-Equity Ratio: -4.8
Current Ratio: 5.9
Quick Ratio: 5.6

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PLUR Technical Analysis vs Fundamental Analysis

Sell
41
Pluri (PLUR) is a Sell

Is Pluri a Buy or a Sell?

  • Pluri stock is rated a Sell
    The current Pluri [PLUR] share price is $5.06. The Score for PLUR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.